Skip to main content
. 2020 Mar 25;7(2):161–170. doi: 10.1007/s40801-020-00186-8

Table 3.

Distribution of ADR symptoms reported within the last year by symptom and gender

Category Level All
n, %
Gender Chi square p value
Male Female
n, % n, %
All All 1226, 100 593, 48.37 633, 51.63 NA
Symptom category Gastrointestinal disorders 720, 58.73 312, 43.33 408, 56.67 < 0.0001
General disorders and administration site conditions 242, 19.74 109, 45.04 133, 54.96 0.2782
Nervous system disorders 259, 21.13 104, 40.15 155, 59.85 0.0036
Psychiatric disorders 92, 7.50 45, 48.91 47, 51.09 0.9999
Skin and subcutaneous tissue disorders 72, 5.87 34, 47.22 38, 52.78 0.9369
Musculoskeletal and connective tissue disorders 29, 2.37 17, 58.62 12, 41.38 0.3524
Cardiac disorders 49, 4.00 24, 48.98 25, 51.02 1.000
Respiratory, thoracic, mediastinal disorders 4, 0.33 1, 25.00 3, 75.00 0.6631
Reproductive system and breast disorders 50, 4.08 46, 92.00 4, 8.00 < 0.0001
Vascular disorders 10, 0.82,00 1, 10.00 9, 90.00 0.0340
Weight increase 39, 3.18 12, 30.77 27, 69.23 0.0382
Renal and urinary disorders 11, 0.90 4, 36.36 7, 63.64 0.6190
Eye disorders 19, 1.55 10, 52.63 9, 47.37 0.8860
Increased appetite 30, 2.45 13, 43.33 17, 56.67 0.0007
Immune system disorders 9, 0.73 5, 55.56 4, 44.44 0.9217
Other symptoms 153, 12.48 93, 60.78 60, 39.22 0.0014

Column reports column percentages

Columns report row percentages